How long does stem cell therapy for Multiple Sclerosis last?
Duration depends on intervention and disease phenotype. Longer follow-up from one AHSCT protocol cannot be transferred to an MSC infusion, and a short MRI or symptom change does not prove durable prevention of progression.
How stem cells are studied for Multiple Sclerosis
Multiple sclerosis is an immune-mediated central-nervous-system disorder that damages myelin, axons and neurons. Autologous haematopoietic stem-cell transplantation (AHSCT) aims to rebuild the immune system after conditioning; it is fundamentally different from an MSC infusion marketed as neural repair. Neither approach should be described as replacing lost brain tissue or universally reversing disability.
Am I a candidate? → · Multiple Sclerosis: full overview → · Multiple Sclerosis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Multiple Sclerosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Multiple Sclerosis cost? (2026)
- Multiple Sclerosis stem cell therapy — your questions answered (2026)
- Multiple Sclerosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Multiple Sclerosis: what the registries show